Publications Database

Abanilla P. K. et al. (2005)

The use of psychostimulants in pervasive developmental disorders.

Psychiatric Quarterly

76(3), pp. 271-281

Read Abstract (New Window)

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Adams J. B. (2007)

Summary of biomedical treatments for autism.

San Diego: CA: Autism Research Institute

Medicines And Healthcare Products Regulatory Agency (2005)

Antipsychotic medicines: licensed products, uses and side effects.

Read Full (New Window)

Agency for Healthcare Research and Quality (2017)

Medical therapies for children with autism spectrum disorder: An update.

Rockville, MD: Agency for Healthcare Research and Quality

Read Abstract (New Window) Read Full (New Window)

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Akhondzadeh S. et al. (2004)

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Journal of Clinical Pharmacy and Therapeutics

29(2), pp.145-150

Read Abstract (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Akkök F. (1995)

The effects of naltrexone in autistic children: report of two cases.

Turkish Journal of Pediatrics

37(1), pp. 19-23

Read Abstract (New Window)

Akyol Ardic Ü. et al. (2017)

Altered response with methylphenidate to ADHD-like symptoms in pervasive developmental disorder: does CES-1 enzyme gene polymorphism have a role

European Child and Adolescent Psychiatry

Summer, 28(2), pp. 89-94.

Read Abstract (New Window) Read Full (New Window)

Alaghband-Rad J. et al. (2013)

Memantine induced speech problem in two patients with autistic disorder.

Daru

21(1), pp. 54

Read Abstract (New Window) Read Full (New Window)

Alderton H. (1970)

Imipramine in childhood nocturnal enuresis: relationship of time of administration to effect.

Canadian Psychiatric Association Journal

102 pp. 197-203

Read Full (New Window)

Alexander R. , Michael D. , Ganghadaran S. (2004)

The use of risperidone in adults with Asperger syndrome.

British Journal of Learning Disabilities

50(99), pp. 109-115.

Read Abstract (New Window)

Ali G. et al. (2016)

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

November, 26(9), pp. 784-791.

Read Abstract (New Window)

Aman M. G. et al. (2014)

A review of atomoxetine effects in young people with developmental disabilities.

Research in Developmental Disabilities

June, 35(6), pp. 1412-1424.

Read Full (New Window)

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. et al. (2009)

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial.

Journal of the American Academy of Child and Adolescent Psychiatry

48(12), pp. 1143-1154

Read Abstract (New Window) Read Full (New Window)